Kevin Foust

Title: Kevin Foust: Innovator in Drug Product Potency Measurement

Introduction

Kevin Foust is a notable inventor based in Poway, California. He has made significant contributions to the field of drug development, particularly in the measurement of drug product potency. His innovative work has implications for the pharmaceutical industry, enhancing the efficacy and safety of drug products.

Latest Patents

Kevin Foust holds a patent for a "Cell-based assay for measuring drug product potency." This invention relates to an in vitro quantitative cell-based assay that utilizes a primary mouse cell model system permissive to viral vector infection. It employs a quantitative high-content image-based system for determining the potency of a transgene-expressing viral vector drug product for lot disposition. This patent represents a significant advancement in the assessment of drug efficacy.

Career Highlights

Kevin Foust is currently employed at Novartis AG, a leading global healthcare company. His role involves research and development in the area of drug potency measurement, where he applies his expertise to improve drug product assessments. His work is crucial in ensuring that pharmaceutical products meet the necessary standards for safety and effectiveness.

Collaborations

Kevin collaborates with various professionals in his field, including his coworker Allan Arman Kaspar. Their combined efforts contribute to the advancement of innovative solutions in drug development.

Conclusion

Kevin Foust's contributions to the field of drug product potency measurement exemplify the importance of innovation in pharmaceuticals. His patent and work at Novartis AG highlight his commitment to enhancing drug safety and efficacy.